● Recruiting

Adjuvant Chemotherapy and Immunotherapy for Completely Resected Small Cell Lung Cancer

Condition: Small Cell Lung Cancer (SCLC) · Sponsor: Alliance Foundation Trials, LLC.

PhasePhase 2

Planned participants65

Who can joinAll sexes, 18 Years to no upper limit

Healthy volunteersNo

About this study

This is a phase II trial of adjuvant chemotherapy and immunotherapy for completely resected small cell lung cancer (SCLC).

This description comes directly from the study's public registry record.

Talk to the study team

Quality Management and Compliance · 617-732-8727 · ClinicalTrials.Queries@alliancefoundationtrials.org

Always discuss trial participation with your own doctor first.

Locations (3)

University of Illinois Chicago	Chicago, Illinois, United States	Recruiting
Dana Farber Cancer Institute	Boston, Massachusetts, United States	Recruiting
University of Virginia Comprehensive Cancer Center	Charlottesville, Virginia, United States	Recruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT07149363